Webinar: Understanding EMA Policy 0070 and Health Canada PRCI Transparency Requirements (June 25)

by Donald McLean, MBA,
Posted on 6/15/2020

REGISTER now for this upcoming webinar!

Title: Understanding EMA Policy 0070 and Health Canada PRCI Transparency Requirements (June 25)

Date: June 25, 2020, 2:00 pm ET (11:00 am PT) REGISTER

Abstract: This Expert Insights webinar will focus on key elements of current transparency regulations, including the background and history of the European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI) requirements for the publication of clinical trial data. Key requirements of both health authorities will be discussed in-depth, including similarities and differences. Additionally, attendees will learn about the future of document sharing and what will be required to disclose publicly in the years to come.

Attendees will learn:

  • Key requirements for EMA Policy 0070,
  • Key requirements for Health Canada PRCI,
  • Similarities and differences between EMA Policy 0070 and Health Canada PRCI,
  • Additional avenues for sharing documents, and
  • The future of clinical document sharing, including technologies to aid in this process

REGISTER HERE

Presenters:

Kelly Vaillant, Director, Global Transparency Strategy & Compliance

Kavita Verma, Senior Transparency Lead

Megan Niner, Transparency Specialist

This is the first part of a two-part series. The second webinar will focus on strategies for ensuring success in implementing EMA Policy 0070 and Health Canada PRCI, scheduled for August 20, 2020.

REGISTER HERE

Share: